Table.

Clinical Characteristics of Subjects With RP

		Manifest Refraction		BCVA
Patient ID	Agea/Gender	Right Eye	Left Eye	Right Eye	Left Eye
P1	56/F	–0.25 DS/−0.75 DC × 22	–1.75 DS/–0.25 DC × 24	20/16	20/20
P2	22/F	Plano	Plano	20/16	20/16
P3	29/M	–4.50 DS/−0.50 DC × 140	–5.00 DS/–0.75 DC × 31	20/16	20/16
P4	59/M	–0.25 DS/–0.50 DC × 135	–0.75 DS	20/16	20/20
P5	43/F	–1.25 DS/−1.25 DC × 66	–1.50 DS/–1.00 DC × 93	20/16	20/20
P6	44/F	–2.25 DS/−2.25 DC × 20	–2.00 DS/–1.50 DC × 169	20/32b	20/25b
P7	53/M	+0.25 DS/−1.00 DC × 72	Plano	20/20c	20/20c
P8	9/F	–0.75 DS	+0.25DS/–0.75 DC × 180	20/25	20/25
P9	52/F	–1.00DS/–1.00 DC × 45	–0.75 DS/–1.00 DC × 165	20/20	20/20
P10	27/F	+0.25 DS/–0.75 DC × 155	Plano/–0.75 DC × 5	20/20	20/20
P11	67/F	+3.00 DS/–0.75 DC × 22	+1.75 DS/–0.50 DC × 159	20/20	20/25

BCVA, best-corrected visual acuity; F, female; M, male; DS, diopter sphere; DC, diopter cylinder.

^aAt first study visit.

^bCystoid macular edema.

^cIntraocular lens.